Member Exclusive

Researchers suggest RIOK 1 as a new target for cancer therapeutics

A group led by Tilman Brummer (University of Freiburg, Breisgau, Germany) has collaborated with an international team of researchers to identify a new target for cancer therapy; RIOK1.

Go to the profile of Rachel Coleby
May 11, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...